Jennison Associates’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Jennison Associates's TRAX Position: Q3 2026 in Review
Jennison Associates opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 499,410 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #344 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Jennison Associates held 499,410 shares of First Tracks Biotherapeutics worth $17.7M as of Q3 2026.
- First Tracks Biotherapeutics was a new Jennison Associates position in Q3 2026.
- First Tracks Biotherapeutics made up 0.01% of Jennison Associates's portfolio in Q3 2026, its #344 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.